Nro. 306
アトリエ (306)
Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment
DOC. 306
Chamber (306)
List No. 306
Himalaya (306)
The 306: Dawn
Case 306
§306 - §312